Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-25

Clinical Trial Update: the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children [NA]

View source ↗

Summary

A completed clinical trial evaluated the potential immunomodulatory effects of Spirulina in children with beta-thalassemia major.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spirulina (spirulina)

Snippet

Sponsor: Tanta University | Conditions: Beta Thalassemia Major | NA | Status: COMPLETED